Data investigation
A Proportion That Rises by Itself
A study of compounded semaglutide reports that body composition improved, with gains in the proportion of lean muscle. The same numbers show 35% of the weight lost was lean tissue.
A study of 94 people taking compounded semaglutide at a commercial wellness studio reports that body composition improved, with gains in the overall proportion of lean muscle.[1] Both halves of that are true. Doing the arithmetic on the same numbers shows that 35% of the weight they lost was lean tissue, and the proportion claim would have been true almost regardless.
The numbers, and what they sum to
Participants at a commercial wellness studio received weekly compounded semaglutide combined with cyanocobalamin, titrated from 0.25 mg toward 2.4 mg, and were measured at three months.
| Measure | Change |
|---|---|
| Total weight | −4.11 kg (SD 2.77), or −4.57% |
| Fat mass | −2.67 kg (2.37) |
| Lean mass | −1.43 kg (1.41) |
| Skeletal muscle mass | −0.88 kg (0.81) |
| Trunk fat mass | −1.10 kg (1.36) |
Fat and lean together account for essentially all of it: 2.67 plus 1.43 is 4.10, against a total of 4.11. So lean tissue made up roughly a third of everything lost.
Fat 2.67 kilograms. Lean 1.43 kilograms. Both went.
Why the proportion went up anyway
That is why the sentence matters. “Body composition improved” and “the proportion of lean muscle increased” are the phrasings a marketing page lifts, and both are compatible with losing a third of your weight as lean tissue.
Is a third high? Not by the range reported for these drugs. A 2024 review found lean tissue making up anywhere from about 15% or less to between 40% and 60% of the weight lost, depending on the trial.[2] The larger imaging evidence is more reassuring. In a trial that compared muscle loss against what population data predicted for the same weight change, the loss was no greater than expected and muscle quality improved more than expected. That work is in muscle volume versus muscle function, and it is a far better instrument than this study.
What this study is, exactly
- Ninety-four people, 81 of them women, average age 46.6.
- Retrospective, with no control group and no randomization.
- Three months, which is the steep early part of the curve.
- A commercial wellness studio, not a clinic or a trial site.
We cover it despite all of that, because it is the only real-world body composition data on a compounded product we have found. Almost everything known about what these drugs do to muscle comes from trials of the branded medicine at controlled doses. What happens with a compounded preparation obtained through a wellness studio has essentially not been studied.
The 4.57% at three months is modest and unremarkable for that point in a titration. It is a real result from real people, and it is not evidence about the compounded product specifically, because nothing here compares it to anything.
The B12 in the syringe
The product was semaglutide combined with cyanocobalamin (vitamin B12). Nothing in this study isolates one from the other, and nobody should read the result as evidence that adding B12 does anything.
There is no evidence base for B12 as a weight-loss agent. Its presence in compounded GLP-1 preparations has more to do with the rules governing what a compounder may prepare than with any expected benefit, which we set out in semaglutide compounded with B12.
What to carry away
- When you read that lean proportion improved, ask what happened in kilograms. The proportion rises on its own.
- Resistance training and adequate protein remain the answer, and nothing here changes that (see protein targets).
- A wellness studio is not a clinical setting. The result may be real and the context is not a trial.
- This tells you almost nothing about compounded product safety, which is a separate question with its own evidence.
Frequently Asked Questions
References
- 1.Chun E, Siojo A, Rivera D, et al. Weight loss and body composition after compounded semaglutide treatment in a real world setting Diabetes, Obesity and Metabolism. 2025. PMID: 39776038.
- 2.Neeland IJ, Linge J, Birkenfeld AL Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Diabetes Obes Metab. 2024. PMID: 38937282.
Compare the sellers
Related research
Is There a Tirzepatide Pill? What Sellers Ship
No tirzepatide pill is FDA-approved: Mounjaro and Zepbound are injections only. We list the sellers offering compounded tablets, drops and lozenges, what they charge, and the approved GLP-1 pills that do exist.
7 min read
What Your Doctor Cannot See
Compounded semaglutide and tirzepatide appear in 8.2% of primary care records. Surveys put real use near 23%, so most of it is invisible to the record and to everything that depends on it.
6 min read
The Drugs Nobody Writes About
A pharmacovigilance study found muscle atrophy reported disproportionately with semaglutide and tirzepatide. The same table shows two older drugs of the same class reported significantly less often than average.
6 min read
Real, and Below the Threshold
Semaglutide improves patient-reported physical functioning by 1.71 points, with an interval excluding zero. The threshold at which a patient notices a change is 3.7 points. Both are true at once.
6 min read
Comparing Trials That Never Met
We refused a cross-trial comparison in an earlier article. This article runs the methodologically proper version of it, and explains why it appears to contradict a head-to-head trial without actually doing so.
7 min read
Another Molecule You Cannot Buy
A dual agonist reported 14.7% weight loss in thirteen weeks. The drug is approved nowhere, and a thirteen-week figure sits on the steepest part of a curve that flattens.
6 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Bodybuilding Health+
Seeing what it charges before you answer any medical questions
From $179/mo
Get started →YourEra
Semaglutide at $99/month, well below the typical price
From $99/mo
Get started →Eden
Coverage in all 50 states, which most sellers will not confirm
From $99/mo
Get started →